1.
Issue Brief Health Policy Track Serv
; 2016: 1-74, 2016 Dec 27.
Article
in English
| MEDLINE
| ID: mdl-28252887
Subject(s)
Drug Approval/legislation & jurisprudence , Drug Industry/legislation & jurisprudence , Government Regulation , United States Food and Drug Administration , Animals , Biosimilar Pharmaceuticals , Clinical Trials as Topic , Commerce/legislation & jurisprudence , Consumer Product Safety/legislation & jurisprudence , Contrast Media , Device Approval/legislation & jurisprudence , Dietary Supplements/adverse effects , Drug Compounding , Drug Labeling , Drug Resistance, Microbial , Drug-Related Side Effects and Adverse Reactions , Drugs, Generic , Drugs, Investigational , Electronic Nicotine Delivery Systems/adverse effects , Fees, Pharmaceutical , Fraud , Humans , Internet/legislation & jurisprudence , Investigational New Drug Application , Nonprescription Drugs , Opioid-Related Disorders , Orphan Drug Production/legislation & jurisprudence , Prescription Drug Misuse , Prescription Drugs , Quality Control , Rare Diseases/drug therapy , Sexual and Gender Minorities , Smoking Prevention , Tobacco Products/legislation & jurisprudence , Tobacco, Smokeless/adverse effects , United States , Vaping/adverse effects , Veterinary Drugs , Zika Virus Infection/drug therapy
2.
Issue Brief Health Policy Track Serv
; : 1-97, 2015 Dec 28.
Article
in English
| MEDLINE
| ID: mdl-27116797